▶Infestation occurs commonly in children attending child care or school.
▶Caused by Pediculus humanus capitis, the human head louse.
▶Less commonly seen in Black children, in relation to diameter and nature and shape of their hair shafts.
▶Transmission mainly via head-to-head contact; less commonly through fomites (eg, combs, hairbrushes, hats, towels, hooded jackets); prevention of spread is best focused on reducing active infestations and minimizing direct head-to-head contact.
▶Affects all socioeconomic groups.
▶Head louse (unlike body louse) does not transmit disease.
▶Head lice are specific to humans and are not spread between humans and pets.
▶Pruritus is the most common symptom, although many children may be asymptomatic, especially during the first weeks of a primary infestation.
▶Secondary excoriation and bacterial infection may be present.
▶Evidence of infestation (eg, live lice, nits, excoriations) is often most apparent behind the ears and at the nape of the neck.
▶Regional (eg, cervical, suboccipital) lymphadenopathy is common if there is secondary bacterial infection.
▶Live lice may be seen and are 2 to 4 mm in length.
▶Nits (eggs) present as 0.5- to 0.8-mm, tan-brown concretions firmly affixed to hair shafts (Figure 43.1).
▶Hatched (nonviable) nits are usually white.
Figure 43.1. Head Lice. Note Numerous Nits Attached to Hair Shafts.

Look-alikes
| Disorder | Differentiating Features |
|---|---|
| Seborrheic dermatitis |
|
| Psoriasis |
|
| Hair casts |
|
| Piedra |
|
| Hair products |
|
▶Clinical examination: Identification of live lice is the criterion standard for diagnosis but can be difficult. The presence of viable nits on hairs (within 1 cm of the scalp) is highly suggestive of active infestation.
▶Viability of nits can be assessed by mounting affected hairs on a glass slide and performing low-power microscopic examination; viable nits have an intact operculum (cap) at the nonattached end, whereas this cap is missing in hatched (nonviable) nits (Figure 43.2).
Figure 43.2. Head Lice. Low-Power Microscopy Reveals a Hatched Nit. Note the Cement-Like Substance Adhering the Nit to the Hair Shaft. The Flat Surface (Reflecting Loss of the Cap, or Operculum) and Absence of a Developing Louse within the e.g.confirms the Hatched Nature of This Nit.

▶Pediculicides are the treatment of choice and include
■Permethrin 1% cream rinse, available over the counter; first-line therapy; applied to hair that has been shampooed and towel dried; left on for 10 minutes and then rinsed; repeat treatment in 7 to 10 days; approved in infants 2 months and older.
■Synergized pyrethrins (pyrethrin + piperonyl butoxide), available in a variety of over-the-counter products; applied to dry hair; also used for 10 minutes; repeat treatment in 7 to 10 days; should not be used in individuals with allergy to chrysanthemums; approved in children 2 years and older.
■Malathion 0.5% lotion, available by prescription; applied to dry hair and rinsed in 8 to 12 hours; repeat therapy in 7 to 10 days if needed; approved in children 6 years and older (some endorse use down to 2 years of age); product is flammable.
■Spinosad 0.9% suspension, a fermentation product of the soil bacterium Saccharopolyspora spinosa; applied to dry hair and rinsed in 10 minutes; repeat therapy in 7 days if needed; approved in infants 6 months and older.
■Ivermectin 0.5% lotion; applied to dry hair and rinsed in 10 minutes; approved in infants 6 months and older.
■Abametapir 0.74% lotion received approval (for infants 6 months and older) but at the time of this writing is not yet available in the United States; applied to dry hair and rinsed in 10 minutes.
■Lindane 1% lotion is not recommended by the American Academy of Pediatrics (AAP) or the Centers for Disease Control and Prevention given concerns over neurotoxicity.
▶Repeat topical therapy (710 days after the initial treatment) is usually recommended to ensure killing of any eggs that hatch after first treatment but may vary by product (see earlier list).
▶Oral ivermectin (200 or 400 mcg/kg single dose) has been used off-label for children older than 2 years who weigh 15 kg or more with resistant disease; it is typically repeated in 9 to 10 days.
▶Alternative off-label therapies include trimethoprim-sulfamethoxazole and suffocation therapies (eg, petroleum jelly, mayonnaise, olive oil); problem with latter is ability of human head louse to close respiratory spiracles temporarily, reopening them after removal of the occlusive agent.
▶Before pediculicidal resistance is suggested, consider other causes of therapeutic failure, like misdiagnosis, repeat infestation, or treatment noncompliance.
▶Manual removal of lice and nits with nit combing of wet hair is possible for those who prefer not to use a pediculicide.
▶There now exist multiple lice-removal salons that offer manual nit removal and non-pediculicidal topical therapies; some also offer hot-air therapy.
▶Close contacts should be examined and treated (if necessary), and bedding and clothing should be machine washed and dried on a high-heat setting. Necessary shared headgear (eg, batting helmets, computer headphones) can be wiped with a damp cloth between uses.
▶No-nit policies, which prevent children with nits from attending child care or school, are not effective and can lead to academic and social struggles for children. The AAP recommends against no-nit policies and discourages routine classroom or school-wide screening for lice. No healthy child should be excluded from or allowed to miss schooltime because of head lice.
▶Secondary bacterial infection should be treated with an appropriate systemic antibiotic.
▶Scalp dermatitis can be treated with topical corticosteroid solution (eg, fluocinolone 0.01% scalp solution, mometasone 0.1% solution).
▶Severe pruritus may necessitate oral antihistamine therapy.
▶Consider referral to a dermatologist for patients with disease that seems to be resistant to standard therapy (after considering misdiagnosis, reinfestation, or treatment noncompliance).
▶An updated head lice clinical report is available at https://publications.aap.org/pediatrics/article/150/4/e2022059282/189566/Head-Lice.
▶American Academy of Pediatrics: HealthyChildren.org.
▶Centers for Disease Control and Prevention: About head lice.
https://www.cdc.gov/lice/about/head-lice.html?CDC_AAref_Val=https://www.cdc.gov/parasites/lice/head
▶MedlinePlus: Information for patients and families (in English and Spanish) sponsored by the US National Library of Medicine and National Institutes of Health.
https://www.nlm.nih.gov/medlineplus/ency/article/000840.htm
▶National Pediculosis Association: Welcome to HeadLice.org.